When Devex and PSI partnered to survey experts on what constitutes a “best buy” for global health, strengthening health systems rose to the top of the list.
But as funding agencies and policymakers demand more and more evidence of impact for every development dollar spent, the pressure is on health care providers to prove value-for-money through measurements like “patients treated” or “vaccines delivered.”
Devex Editor Rolf Rosenkranz sat down with PSI President and CEO Karl Hofmann to learn how his organization is exploring “unconventional financing” options to sustain funding for health outcomes in the developing world.
In the below video clip, Hofmann describes the challenge compile evidence that health investments lead to measurable outcomes.
PSI has pioneered social marketing to expand health services to underserved populations and is now exploring new opportunities for “social franchising” to link medical entrepreneurs with the kinds of training and market research PSI can provide.
This story is part of Best Buys in Global Health, a campaign by PSI, PATH and Devex to highlight sound investments in global health. Find out more.
Watch more development aid videos online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.
About the author
Michael Igoe@AlterIgoe
Michael Igoe is a Senior Reporter with Devex, based in Washington, D.C. He covers U.S. foreign aid, global health, climate change, and development finance. Prior to joining Devex, Michael researched water management and climate change adaptation in post-Soviet Central Asia, where he also wrote for EurasiaNet. Michael earned his bachelor's degree from Bowdoin College, where he majored in Russian, and his master’s degree from the University of Montana, where he studied international conservation and development.
